| 摘要 |
The invention relates to new competitive inhibitors of thrombin, their synthesis, pharmaceutical compositions containing the compounds as active ingredients, and the use of the compounds as anticoagulants for prophylaxis and treatment of thromboembolic diseases, according to formula (I) wherein A represents a methylene group, an ethylene group or a propylene group, which may be substituted or A represents -CH2-O-CH2-, -CH2-S-CH2-, -CH2-SO-CH2-, or A represents -CH2-O-, -CH2-S-, -CH2-SO-, with the heteroatom functionality in position 4, or n is an integer 2 to 6; and B represents -N(R<6>)-C(NH)-NH2, wherein R<6> is H or a methyl group, or B represents -S-C(NH)-NH2, or -C(NH)-NH2. Further described is new use in synthesis of pharmaceutical compounds of a compound of formula (II). |
